The $1.5B+ biotech frontier is being redefined.
Rapid Dose Therapeutics $DOSE is scaling its #QuickStrip technology into global markets like Brazil,disrupting the sports medicine landscape. Precision delivery + massive market gap = high-growth potential $RDTCF #SmallCap#Biotech
🚨 $RDTCF is officially live.
Rapid Dose Therapeutics is now trading on the OTCQB! 🇺🇸 This move expands access for U.S. healthcare & biotech investors to RDT’s proprietary QuickStrip™ delivery platform
https://t.co/AVYwCR83re
$RDTCF $DOSE #OTCQB#Biotech#Investing
Rapid Dose Therapeutics Corp (CSE: $DOSE | OTCQB: $RDTCF) launches its QuickStrip™ medical cannabis oral thin film in Brazil following ANVISA regulatory approval for sublingual and buccal administration.
https://t.co/aFhr11lGkS
#OTCQB#OTCMarkets#MedicalCannabis#Healthcare
Rapid Dose Therapeutics is a Canadian #biotechnology company revolutionizing drug delivery through innovation. The Company’s flagship product #QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients #OTF#OralThinFilm
Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip™ to Combat #Opiate#Addiction Crisis
https://t.co/1NOZ14rONP
#Quickstrip#OralThinFilm#FirstNations
In a recent interview with @ceodotca , Mark Upsdell, CEO of Rapid Dose Therapeutics (CSE: DOSE), discussed their game-changing QuickStrip technology that delivers medication "right into your bloodstream".
In June, QuickStrip™ by RDT was featured in @RecoverCann’s WGY6 campaign for Men’s Mental Health and PTSD Awareness Month—spotlighting wellness-oriented innovations.
#CBD#OralThinFilm#QuickStrip